A leukemia therapy in which a patient's lymphocytes are genetically modified to attack the tumor cells causing the disease has shown dramatic effects in five patients, according to a new study.
The treatment appeared to eliminate cancer cells that had grown back after initially being beaten down by chemotherapy. Patients were then able to undergo bone marrow transplants, a grueling but sometimes curative procedure.
Might the "immunotherapy" have been curative on its own? That is the biggest of several unanswered questions.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.